Acorah Software Products - Accounts Production 16.6.950 false true 29 February 2024 1 March 2023 false 1 March 2024 28 February 2025 28 February 2025 06111707 Mr. Damien Repelowicz Mr Denis Repelowicz true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 06111707 2024-02-29 06111707 2025-02-28 06111707 2024-03-01 2025-02-28 06111707 frs-core:CurrentFinancialInstruments 2025-02-28 06111707 frs-core:FurnitureFittings 2025-02-28 06111707 frs-core:FurnitureFittings 2024-03-01 2025-02-28 06111707 frs-core:FurnitureFittings 2024-02-29 06111707 frs-core:ShareCapital 2025-02-28 06111707 frs-core:RetainedEarningsAccumulatedLosses 2025-02-28 06111707 frs-bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 06111707 frs-bus:FilletedAccounts 2024-03-01 2025-02-28 06111707 frs-bus:SmallEntities 2024-03-01 2025-02-28 06111707 frs-bus:AuditExempt-NoAccountantsReport 2024-03-01 2025-02-28 06111707 frs-bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 06111707 frs-bus:OrdinaryShareClass1 2024-03-01 2025-02-28 06111707 frs-bus:OrdinaryShareClass1 2025-02-28 06111707 1 2024-03-01 2025-02-28 06111707 frs-core:CostValuation 2024-02-29 06111707 frs-core:AdditionsToInvestments 2025-02-28 06111707 frs-core:DisposalsRepaymentsInvestments 2025-02-28 06111707 frs-core:CostValuation 2025-02-28 06111707 frs-core:ProvisionsForImpairmentInvestments 2024-02-29 06111707 frs-core:ProvisionsForImpairmentInvestments 2025-02-28 06111707 frs-core:UnlistedNon-exchangeTraded 2025-02-28 06111707 frs-core:UnlistedNon-exchangeTraded 2024-02-29 06111707 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-02-29 06111707 frs-core:AdditionsToInvestments frs-core:UnlistedNon-exchangeTraded 2025-02-28 06111707 frs-core:DisposalsRepaymentsInvestments frs-core:UnlistedNon-exchangeTraded 2025-02-28 06111707 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2025-02-28 06111707 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-02-29 06111707 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2025-02-28 06111707 frs-bus:Director1 2024-03-01 2025-02-28 06111707 frs-bus:Director2 2024-03-01 2025-02-28 06111707 frs-countries:EnglandWales 2024-03-01 2025-02-28 06111707 2023-02-28 06111707 2024-02-29 06111707 2023-03-01 2024-02-29 06111707 frs-core:CurrentFinancialInstruments 2024-02-29 06111707 frs-core:ShareCapital 2024-02-29 06111707 frs-core:RetainedEarningsAccumulatedLosses 2024-02-29 06111707 frs-bus:OrdinaryShareClass1 2023-03-01 2024-02-29
Registered number: 06111707
Medi-Europe Ltd
Unaudited Financial Statements
For The Year Ended 28 February 2025
Adbell Advisory Limited
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 06111707
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 - 165
Investments 5 50 32,577
50 32,742
CURRENT ASSETS
Debtors 6 118,970 95,734
Cash at bank and in hand - 48,543
118,970 144,277
Creditors: Amounts Falling Due Within One Year 7 (1,500 ) (57,962 )
NET CURRENT ASSETS (LIABILITIES) 117,470 86,315
TOTAL ASSETS LESS CURRENT LIABILITIES 117,520 119,057
NET ASSETS 117,520 119,057
CAPITAL AND RESERVES
Called up share capital 8 100 100
Profit and Loss Account 117,420 118,957
SHAREHOLDERS' FUNDS 117,520 119,057
Page 1
Page 2
For the year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr. Damien Repelowicz
Director
27/11/2025
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Medi-Europe Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 06111707 . The registered office is Birchin Court, 20 Birchin Lane, London, EC3V 9DJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover represents the company's share of profit in the partnership which provides consultancy services.
2.3. Tangible Fixed Assets and Depreciation
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value offixture and fittings over its estimated useful life.
25% - straight line basis
Fixtures & Fittings Furniture
2.4. Financial Instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset , with the net amounts presented in the financial statements , when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
2.5. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.6. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
2.7. Cash and cash equivalents
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings incurrent liabilities.
Page 3
Page 4
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Tangible Assets
Fixtures & Fittings
£
Cost
As at 1 March 2024 7,056
Disposals (7,056 )
As at 28 February 2025 -
Depreciation
As at 1 March 2024 6,891
Disposals (6,891 )
As at 28 February 2025 -
Net Book Value
As at 28 February 2025 -
As at 1 March 2024 165
5. Investments
Unlisted Other Total
£ £ £
Cost
As at 1 March 2024 32,577 - 32,577
Additions - 50 50
Disposals (32,577 ) - (32,577 )
As at 28 February 2025 - 50 50
Provision
As at 1 March 2024 - - -
As at 28 February 2025 - - -
Net Book Value
As at 28 February 2025 - 50 50
As at 1 March 2024 32,577 - 32,577
The company has 5% interest in a partnership whose principal place of business is outside the United Kingdom. The share of profits in the partnership for the year amounts to £3,083 (2024 : Nil). The share of net assets in the partnership amounts to £119,020 (2024 : Nil).
6. Debtors
2025 2024
£ £
Due within one year
Other debtors - 92,692
VAT - 3,042
Amounts owed by other participating interests 118,970 -
118,970 95,734
Page 4
Page 5
7. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors - 15,695
Corporation tax - 39,267
Accruals and deferred income 1,500 3,000
1,500 57,962
8. Share Capital
2025 2024
Allotted, called up and fully paid £ £
100 Ordinary Shares of £ 1.00 each 100 100
9. Ultimate Controlling Party
The company's ultimate controlling parties are Mr Damien Repelowicz and Ms Marine Repelowicz.
Page 5